Bellevue Asset Management, LLC Neogenomics Inc Transaction History
Bellevue Asset Management, LLC
- $194 Million
- Q3 2024
A detailed history of Bellevue Asset Management, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Bellevue Asset Management, LLC holds 112 shares of NEO stock, worth $1,588. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112
Previous 112
-0.0%
Holding current value
$1,588
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NEO
# of Institutions
291Shares Held
124MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$279 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$199 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$97.7 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$93.6 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$92.8 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.78B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...